Board approves investment and ₹75 cr loan proposal for capacity expansion
ANUHPHR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.9 pts more than Nifty Microcap 250 and 5.7 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The board of Anuh Pharma has approved investment in manufacturing assets to expand production capacity. It also approved a proposal to avail a loan of up to ₹75 crores to fund the purchase of these manufacturing assets. Loan terms are yet to be finalised and are subject to applicable approvals.
Positive growth signal, but the new loan will add to debt and interest costs going forward.